Suppr超能文献

英格兰、威尔士和北爱尔兰国民保健署乳腺癌筛查计划中的间期癌。

Interval cancers in the NHS breast cancer screening programme in England, Wales and Northern Ireland.

机构信息

Cancer Screening Evaluation Unit, Institute of Cancer Research, 15 Cotswold Road, Sutton, Surrey SM2 5 NG, UK.

出版信息

Br J Cancer. 2011 Feb 15;104(4):571-7. doi: 10.1038/bjc.2011.3. Epub 2011 Feb 1.

Abstract

BACKGROUND

The United Kingdom NHS Breast Screening Programme was established in 1988, and women aged between 50 and 70 are routinely invited at three yearly intervals. Expected United Kingdom interval cancer rates have been calculated previously, but this is the first publication from an exercise to collate individual-based interval cancer data at a national level.

METHODS

Interval cancer case ascertainment is achieved by the regular exchange of data between Regional Breast Screening Quality Assurance Reference Centres and Cancer Registries. The present analysis includes interval cancers identified in women screened between 1st April 1997 and 31st March 2003, who were aged between 50 and 64 at the time of their last routine screen.

RESULTS

In the periods >0-<12 months, 12-<24 months and 24-<36 months after a negative screen, we found overall interval cancer rates and regional ranges of 0.55 (0.43-0.76), 1.13 (0.92-1.47) and 1.22 (0.93-1.57) per 1000 women screened, respectively. Rates in the period 33-<36 months showed a decline, possibly associated with early re-screening or delayed presentation.

CONCLUSIONS

Interval cancer rates were higher than the expected rates in the 24-month period after a negative screen, but were similar to published results from other countries. Increases in background incidence may mean that the expected rates are underestimated. It is also possible that, as a result of incomplete case ascertainment, interval cancers rates were underestimated in some regions in which rates were less than the expected.

摘要

背景

英国国民保健制度(NHS)乳房筛查计划于 1988 年成立,50 至 70 岁的女性每三年定期接受邀请。此前已计算出预期的英国间隔期癌症发生率,但这是首次从一项在全国范围内汇总个体间隔期癌症数据的工作中发表的出版物。

方法

通过区域乳房筛查质量保证参考中心和癌症登记处之间定期数据交换来确定间隔期癌症病例。本分析包括在 1997 年 4 月 1 日至 2003 年 3 月 31 日期间接受筛查、最后一次常规筛查时年龄在 50 至 64 岁之间的女性中发现的间隔期癌症。

结果

在阴性筛查后>0-<12 个月、12-<24 个月和 24-<36 个月的时间段内,我们发现总体间隔期癌症发生率和区域范围分别为 0.55(0.43-0.76)、1.13(0.92-1.47)和 1.22(0.93-1.57)每千名筛查妇女中,分别有。33-<36 个月期间的发病率下降,可能与早期重新筛查或延迟就诊有关。

结论

阴性筛查后 24 个月的间隔期癌症发生率高于预期发生率,但与其他国家公布的结果相似。背景发病率的增加可能意味着预期发生率被低估。也有可能由于不完全的病例确定,在一些发病率低于预期的地区,间隔期癌症的发生率被低估了。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b7f4/3049599/d958929fc4d7/bjc20113f1.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验